Wink, CSD; Meyer, GMJ; Wissenbach, DK; Jacobsen-Bauer, A; Meyer, MR; Maurer, HH. Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): Metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS. Drug Test. Anal., 1 Oct 2014, 6 (10), 1038-1048. 674 kB. https://doi.org/10.1002/dta.1621 #NEDPA
EMCDDA. New drugs in Europe, 2014, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2015. 879 kB.
Westphal, F; Junge, T; Jacobsen-Bauer, A; Rõsner, P. Lefetamin-Derivate: alte Bekannte neu auf dem Drogenmarkt. Toxichem Krimtech, 1 Jan 2010, 77 (1), 46–58. 115 kB. #2 MS
Wallach, J; Brandt, SD. 1,2-Diarylethylamine- and ketamine-based new psychoactive substances. In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 305-352. 593 kB. https://doi.org/10.1007/164_2018_148 #Ephenidine
Hägele, JS; Basrak, M; Schmid, MG. Enantioselective separation of novel psychoactive substances using a Lux® AMP 3 μm column and HPLC-UV. J. Pharm. Biomed. Anal., 5 Feb 2020, 179, 112967. 3.6 MB. https://doi.org/10.1016/j.jpba.2019.112967 #H LC